12:00 AM
 | 
Apr 26, 2004
 |  BioCentury  |  Finance

EPS watch

EPS watch

Company 1Q04 EPS est 1Q04 EPS actual Outcome Growth from 1Q03 4/23 cls Wk chg %chg Mcap chg ($M) 4/23 Mcap ($B)
Affymetrix (AFFX) (A) -$0.08 -$0.03 Beat by $0.05 NA $31.39 -$3.62 -10% $(219.1) $1.9
For 2Q04, the company expects EPS of $0.03 on revenues of $78M. Analysts had expected EPS of $0.14 in the second quarter. The company also said that certain SG&A expenses that were expected in 1Q04 will now come in 2Q04.
Amgen (AMGN) $0.56 $0.57 Beat by $0.01 36% $58.31 -$1.83 -3% $(2,350.7) $74.9
Product sales were $2.2B, up 35% from $1.6B in 1Q03 (see "EPO Sales Watch," A15).
Celgene (CELG) $0.08 $0.10 Beat by $0.02 900% $56.94 $4.53 9%

Read the full 812 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >